VEGF-A and FLT-1 tumour gene expressions are of prognostic value in small cell lung cancer (SCLC) patients treated with first-line ACE chemotherapy

VEGF-A and FLT-1 tumour gene expressions are of prognostic value in small cell lung cancer (SCLC) patients treated with first-line ACE chemotherapy

書誌詳細
主要な著者:	Brueckl, WM, Wirtz, R, Dimmler, A, Brunner, T, Klein, P, Hahn, E, Ficker, J, Wiest, G
フォーマット:	Journal article
出版事項:	2009

類似資料

TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study
著者:: Papadopoulos Thomas, 等
出版事項: (2007-08-01)

Development and Validation of a Simplified Prognostic Score in SCLC
著者:: Elodie Negre, MD, 等
出版事項: (2020-03-01)

Understanding SCLC heterogeneity and plasticity in cancer metastasis and chemotherapy resistance
著者:: Jin Yujuan, 等
出版事項: (2023-05-01)

Exploring the prognostic impact of differences in treatment strategies for SCLC with different histologies and prognostic factors for C-SCLC: A SEER population-based study
著者:: Jiaping Liu, 等
出版事項: (2024-06-01)

Synchronous Oligometastasis and Oligoprogression as a Prognostic Marker in Patients With Extensive-Stage SCLC Treated With a Combination of Immune-Checkpoint Inhibitor and Chemotherapy (HOT2301)
著者:: Kana Hashimoto, MD, 等
出版事項: (2024-11-01)

Clinicopathological Difference and Survival Impact of Patients with c-SCLC and SCLC
著者:: Zhang C, 等
出版事項: (2021-10-01)

Survival, Chemotherapy and Chemosensitivity Predicted by CTC Cultured In Vitro of SCLC Patients
著者:: Lixia Ju, 等
出版事項: (2021-06-01)

Resveratrol reduces drug resistance of SCLC cells by suppressing the inflammatory microenvironment and the STAT3/VEGF pathway
著者:: Cong Hou, 等
出版事項: (2021-08-01)

Clinically relevant prognostic and predictive markers for immune-checkpoint-inhibitor (ICI) therapy in non-small cell lung cancer (NSCLC)
著者:: Wolfgang M. Brueckl, 等
出版事項: (2020-12-01)

Chemotherapy- and Immune-Related Gene Panel in Prognosis Prediction and Immune Microenvironment of SCLC
著者:: Meng-Yu Chen, 等
出版事項: (2022-06-01)

Potential immunologic and prognostic roles of CHRNA6 in SCLC and pan-cancer
著者:: Qingqing Zhao, 等
出版事項: (2024-10-01)

DNA methylation regulates expression of <it>VEGF-R2 </it>(<it>KDR</it>) and <it>VEGF-R3 </it>(<it>FLT4</it>)
著者:: Quentmeier Hilmar, 等
出版事項: (2012-01-01)

AN UNORTHODOX PRESENTATION OF SCLC
著者:: Ruchee Khanna
出版事項: (2018-10-01)

Validity test of small cell lung cancer (SCLC) graded prognostic assessment and proposal of a new index for patients with brain metastases from SCLC
著者:: Masaaki Yamamoto, 等
出版事項: (2024-09-01)

Efficacy and Safety of Anlotinib for Elderly Patients with Previously Treated Extensive-Stage SCLC and the Prognostic Significance of Common Adverse Reactions
著者:: Song PF, 等
出版事項: (2020-11-01)

Chemotherapy for small cell lung cancer (SCLC): standards of care for first presentation and relapse
著者:: Graham Ross
出版事項: (2004-03-01)

New developments in immunotherapy for SCLC
著者:: Zhonglin Hao, 等
出版事項: (2025-01-01)

The prognostic implications of Notch1, Hes1, Ascl1, and DLL3 protein expression in SCLC patients receiving platinum-based chemotherapy.
著者:: Salomon Tendler, 等
出版事項: (2020-01-01)

Clinical value of serum VEGF and sFlt-1 in pernicious placenta previa
著者:: Na Wang, 等
出版事項: (2021-01-01)

Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens
著者:: Tamara Castaño-Bonilla, 等
出版事項: (2021-10-01)

VEGF, FLT3 ligand, PlGF and HGF can substitute for M-CSF to induce human osteoclast formation: implications for giant cell tumour pathobiology.
著者:: Taylor, R, 等
出版事項: (2012)

Roles of VEGF-Flt-1 signaling in malignant behaviors of oral squamous cell carcinoma.
著者:: Ajiravudh Subarnbhesaj, 等
出版事項: (2017-01-01)

Coregulation of Glucose Uptake and Vascular Endothelial Growth Factor (VEGF) in Two Small-Cell Lung Cancer (SCLC) Sublines In Vivo and In Vitro
著者:: Minna W.B. Pedersen, 等
出版事項: (2001-01-01)

What's New in SCLC? A Review
著者:: Bryan Oronsky, 等
出版事項: (2017-10-01)

Combined SCLC clinical and pathological aspects
著者:: Filiz Çimen, 等
出版事項: (2022-06-01)

Combination of chemotherapy and immune checkpoint therapy by the immunoconjugates-based nanocomplexes synergistically improves therapeutic efficacy in SCLC
著者:: Zhang Tao, 等
出版事項: (2022-12-01)

Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurin
著者:: Frank G. Rücker, 等
出版事項: (2024-12-01)

Characterization of a new small cell lung cancer (SCLC) cell line STP54 derived from a metastatic bioptate of a combined type of SCLC with Non-SCLC component.
著者:: Joanna Domagała-Kulawik, 等
出版事項: (2009-05-01)

Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy
著者:: Kim Byoung-Gie, 等
出版事項: (2008-10-01)

VEGF-R1/Flt-1 Receptor as a Characteristic of the Angiogenic Phenotype of Uveal Melanoma
著者:: V. G. Likhvantseva, 等
出版事項: (2021-12-01)

The soluble VEGF receptor sFlt-1 contributes to endothelial dysfunction in IgA nephropathy.
著者:: Yaling Zhai, 等
出版事項: (2020-01-01)

Acute Pulmonary Actinomycosis Induced by Immunotherapy and Chemotherapy Used for SCLC Treatment: A Case Report and Literature Review
著者:: Kuang J, 等
出版事項: (2023-12-01)

Precise prediction of the sensitivity of platinum chemotherapy in SCLC: Establishing and verifying the feasibility of a CT-based radiomics nomogram
著者:: Yanping Su, 等
出版事項: (2023-03-01)

A Real-World Evaluation of Atezolizumab Plus Platinum-Etoposide Chemotherapy in Patients With Extensive-Stage SCLC in Canada
著者:: Anifat A. Elegbede, MSc, MbChB, 等
出版事項: (2021-12-01)

Assessment of targets of antibody drug conjugates in SCLC
著者:: Abhishek Ajay, 等
出版事項: (2025-01-01)

Arginine Deprivation in SCLC: Mechanisms and Perspectives for Therapy
著者:: Carpentier J, 等
出版事項: (2022-09-01)

Impact of Socioeconomic Factors on Overall Survival in SCLC
著者:: Logan Roof, MD, 等
出版事項: (2022-07-01)

Apatinib as Salvage Therapy for Heavily Pretreated SCLC
著者:: Fangfang LI, 等
出版事項: (2018-07-01)

Elevated soluble VEGF receptor sFlt-1 correlates with endothelial injury in IgA nephropathy.
著者:: Ya-Ling Zhai, 等
出版事項: (2014-01-01)

The predictive value of YAP-1 and POU2F3 for the efficacy of immuno-chemotherapy in extensive-stage SCLC patients
著者:: Yu-Qing Chen, 等
出版事項: (2023-01-01)